Key result
Gemfibrozil protocol launches in the Brisighella Heart Study to evaluate cardiovascular events in high-risk hypercholesterolemia.
Why the study?
The Brisighella Study aimed to monitor risk factors for atherosclerosis and CHD incidence and to reduce CHD risk through dietary modification and pharmacologic intervention in a rural population.
Does a nutritional education program and gemfibrozil reduce the incidence of CHD in a rural population with high cholesterol?
Cohort
No
Does a nutritional education program and gemfibrozil reduce the incidence of CHD in a rural population with high cholesterol?
The Brisighella Heart Study established a strong correlation between increased cholesterol and CHD incidence in an Italian rural population, leading to dietary and pharmacological interventions.
No takes yet. Share an insight, caveat, or question.
Nutritional education plus gemfibrozil may aid cholesterol control in rural cohorts; leaves open CHD incidence reduction without randomized confirmation.
G. C. Descovich (1990) conducted a cohort in Coronary heart disease and atherosclerosis. Gemfibrozil was evaluated on Fatal and non-fatal cardiovascular events. The Brisighella Heart Study initiated a high-risk arm treating participants with total cholesterol >239 mg/dl with 600 mg twice-daily gemfibrozil, with follow-up planned for at least 5 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: